You just read:

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy

News provided by

BioDelivery Sciences International, Inc.

Dec 08, 2014, 07:00 ET